Clinical Trial

It is an Observational Study That Compare Prognosis of Typical and Atypical Systemic Lupus Erythematosus Presentation

Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
Atypical presentations of SLE including unusual initial symptoms, predominant organ involvement, late-onset disease and ANA-negative remain poorly characterized. These forms are often associated with delayed diagnosis and potentially worse clinical outcomes. Most existing studies focus on isolated rare manifestations rather than analyzing atypical SLE as a cohesive category. Understanding these differences is crucial and this study aims to compare atypical and typical SLE presentations to clarify variations in prognosis, treatment requirements and subsequent organ involvement.
Trial Details
NCT Number NCT07350772
Lead Sponsor Sohag University
Conditions Systemic Lupus Erythematosus (SLE)
Enrollment 400 participants
Start Date 2026-02-20
Primary Completion 2027-02 (estimated)
Study Completion 2027-08 (estimated)
Updated on ClinicalTrials.gov 2026-01-20